Rigel Pharmaceuticals RIGL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.41M-1.0% | $2.42M+8.4% | $2.42M+26.1% | $2.43M+51.8% | $2.43M+89.9% | ||
| $12.84M+21.4% | $12.71M+2.6% | $12.05M-1.5% | $11.33M-1.8% | $10.58M-5.4% | ||
| $79.27M+123% | $75.66M+140% | $68.18M+536% | $65.83M+635% | $35.59M+633% | ||
| —— | $5M0.0% | $5M+33.3% | $5M+100% | $5M+300% | ||
| -$89.79M— | -$92.37M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $20.21M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rigel Pharmaceuticals generate?
- Rigel Pharmaceuticals (RIGL) generated $79.3M in operating cash flow over the trailing twelve months.
- Where does Rigel Pharmaceuticals's cash flow data come from?
- Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
